I heard that QFS Sodium Hyaluronate is one of the best joint therapy products you will come across.
Sodium hyaluronate (hyaluronic acid—HA) products have been used successfully for years to treat joint disease in several species including the horse. HA is a normal component of joint fluid and cartilage and serves many functions, one of which is to "lubricate" the soft tissue structures of the joint and decrease inflammation. Until recently, HA products were given only as intra-articular injections, directly into the joint space. Now there is an HA preparation that can be given intramuscularly (I.M.) and has shown beneficial results.
Although the mechanism of action of HA is not entirely understood, it is recognized that sodium hyaluronate decreases synovial fluid inflammatory mediators (destructive enzymes) which may have a degradative effect upon articular cartilage.
In addition to the anti-inflammatory actions, HA acts as a lubricating substance within the joint and provides a "protective barrier" over the synovial membrane.
Sodium Hyaluronate is the joint disease therapy that helps stop acute damage before it becomes chronic. Sodium Hyaluronate (hyaluronic acid), is the same polysaccharide present in normal joint fluid to protect and lubricate joint cartilage and soft tissues. Sodium Hyaluronate is produced by a biofermentation process, resulting in such purity that it can be given intramuscularly for immediate bioavailability.
A Colorado State University study* demonstrated systemic administration of Sodium Hyaluronate significantly decreased the synovial fluid concentrations of prostaglandins, glycosaminoglycan (GAG), and total protein that are associated with inflammatory joint disease in the horse. The systemic administration of Sodium Hyaluronate also decreased the severity of cellular infiltration and vascularity in the synovial membrane (i.e., decreased inflammation at the synovial membrane level). This study demonstrates that systemic administration of Sodium Hyaluronate decreases inflammation, products associated with inflammation, and the degree of lameness in horses with arthritis (joint inflammation).
Sodium hyaluronate (hyaluronic acid—HA) products have been used successfully for years to treat joint disease in several species including the horse. HA is a normal component of joint fluid and cartilage and serves many functions, one of which is to "lubricate" the soft tissue structures of the joint and decrease inflammation. Until recently, HA products were given only as intra-articular injections, directly into the joint space. Now there is an HA preparation that can be given intramuscularly (I.M.) and has shown beneficial results.
Although the mechanism of action of HA is not entirely understood, it is recognized that sodium hyaluronate decreases synovial fluid inflammatory mediators (destructive enzymes) which may have a degradative effect upon articular cartilage.
In addition to the anti-inflammatory actions, HA acts as a lubricating substance within the joint and provides a "protective barrier" over the synovial membrane.
Sodium Hyaluronate is the joint disease therapy that helps stop acute damage before it becomes chronic. Sodium Hyaluronate (hyaluronic acid), is the same polysaccharide present in normal joint fluid to protect and lubricate joint cartilage and soft tissues. Sodium Hyaluronate is produced by a biofermentation process, resulting in such purity that it can be given intramuscularly for immediate bioavailability.
A Colorado State University study* demonstrated systemic administration of Sodium Hyaluronate significantly decreased the synovial fluid concentrations of prostaglandins, glycosaminoglycan (GAG), and total protein that are associated with inflammatory joint disease in the horse. The systemic administration of Sodium Hyaluronate also decreased the severity of cellular infiltration and vascularity in the synovial membrane (i.e., decreased inflammation at the synovial membrane level). This study demonstrates that systemic administration of Sodium Hyaluronate decreases inflammation, products associated with inflammation, and the degree of lameness in horses with arthritis (joint inflammation).
